Equity - USD ($)
|
|
|
|
1 Months Ended |
12 Months Ended |
|
Oct. 15, 2024 |
Jun. 05, 2024 |
Jun. 12, 2023 |
May 31, 2024 |
Oct. 26, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Jan. 01, 2024 |
Share-Based Compensation Expense Allocated to Research and Development |
|
|
|
|
|
$ 20,000
|
$ 900,000
|
|
Share-Based Compensation Expense Allocated to General and Administrative |
|
|
|
|
|
10,275,914
|
5,897,594
|
|
Total Compensation and Benefits Expense |
|
|
|
|
|
9,473,513
|
867,359
|
|
Proceed from stock issuances |
|
|
|
|
|
5,602,269
|
485,000
|
|
Director Compensation Expense - Equity |
|
|
|
|
|
$ 1,511,086
|
$ 89,502
|
|
Expected Dividends |
|
|
|
|
|
0.00%
|
0.00%
|
|
Discount on Stock Issuance |
$ 26,863
|
|
|
|
|
|
|
|
Closing market price per share |
$ 21.50
|
|
|
|
|
$ 21.50
|
|
|
Total intrinsic value of all the Company's outstanding options |
$ 14,000,000.0
|
|
|
|
|
$ 2,900,000
|
|
|
Weighted Average Recognition Period |
|
|
|
|
|
3 months 18 days
|
|
|
Unrecognized compensation expense |
|
|
|
|
|
$ 133,257
|
|
|
Common stock and treasury shares, Description |
|
|
|
|
1-for-6 basis and (ii) decrease the number of total authorized shares of common stock of the Company from 150,000,000 to 25,000,000 shares
|
|
|
|
Common stock shares issuance |
|
|
|
|
|
793,489
|
437,692
|
|
Reverse stock split of common stock |
|
|
|
|
As of the Effective Time, every 6 shares of issued and outstanding common stock were converted into one share of common stock
|
|
|
|
Agents fee |
|
|
|
|
|
$ 337,682
|
|
|
Common stock, par value |
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
Remining shares available for issuance |
|
|
|
|
|
789,324
|
|
|
Volatility range |
|
|
|
|
|
122.46%
|
112.28%
|
|
Common stock value |
|
|
|
|
|
$ 3,621
|
$ 2,383
|
|
Private Investors [Member] |
|
|
|
|
|
|
|
|
Common stock shares issuance |
|
|
|
|
|
|
563,016
|
|
Restricted Stock [Member] |
|
|
|
|
|
|
|
|
Weighted Average Recognition Period |
|
|
|
|
|
2 months 12 days
|
|
|
Unrecognized compensation expense |
|
|
|
|
|
$ 31,135
|
|
|
Fair market value of RSAs vested |
|
|
|
|
|
2,507,934
|
|
|
Restricted Stock [Member] | Director Stock Option Replacement Program [Member] |
|
|
|
|
|
|
|
|
Restricted stock were granted under the director equity plan |
|
127,364
|
|
|
|
|
|
|
Recognized expense stock option replacement program |
|
$ 671,998
|
|
|
|
|
|
|
Outstanding number of option |
|
62,451
|
|
|
|
|
|
|
Awarded number of restricted stock issue values |
|
|
|
$ 299,996
|
|
|
|
|
Awarded number of restricted stock |
|
|
|
37,688
|
|
|
|
|
Awarded number of restricted stock per share |
|
|
|
$ 7.96
|
|
|
|
|
Restricted Stock [Member] | Stoc Award Lieuof Unpaid Directors Fees [Member] |
|
|
|
|
|
|
|
|
Accounts payable to related party |
|
|
|
$ 172,670
|
|
|
|
|
Restricted stock were granted under the director equity plan |
|
|
|
261,619
|
|
|
|
|
Recognized expense stock option replacement program |
|
|
|
$ 2,077,523
|
|
|
|
|
Awarded number of restricted stock per share |
|
|
|
$ 7.96
|
|
|
|
|
Non-employee board members fee |
|
|
|
$ 172,670
|
|
|
|
|
Description related to unpaid director fees |
|
|
|
unpaid amounts were grossed up for taxes at an assumed tax rate of 45% and the number of shares was determined based on the Company’s closing stock price on December 29, 2023, of $1.20 per share
|
|
|
|
|
Fair Value Measurement, Discount |
|
|
|
$ 21,121
|
|
|
|
|
On July 5, 2023 |
|
|
|
|
|
|
|
|
Proceed from stock issuances |
|
|
|
|
|
$ 171,666
|
|
|
Purchase price |
|
|
|
|
|
$ 16.02
|
|
|
Agents fee |
|
|
|
|
|
$ 365,000
|
|
|
Common stock, par value |
|
|
|
|
|
$ 0.001
|
|
|
Exercise price |
|
|
|
|
|
$ 0.0006
|
|
|
Pre-funded warrants |
|
|
|
|
|
78,021
|
|
|
Gross proceeds of stock |
|
|
|
|
|
$ 4,000,000
|
|
|
Offering price |
|
|
|
|
|
$ 16.0194
|
|
|
Common stock share issued, restricted |
|
|
|
|
|
78,021
|
|
|
Board Of Directors [Member] |
|
|
|
|
|
|
|
|
Expenses for options and warrants granted to employees58 |
|
|
|
|
|
$ 9,473,513
|
|
|
Epenses for R & D obligation |
|
|
|
|
|
2,222,806
|
|
|
Expenses was attributed to G & A |
|
|
|
|
|
7,250,707
|
|
|
Share-Based Compensation Expense Allocated to Research and Development |
|
|
|
|
|
232,920
|
|
|
Share-Based Compensation Expense Allocated to General and Administrative |
|
|
|
|
|
634,439
|
|
|
Total Compensation and Benefits Expense |
|
|
|
|
|
$ 867,359
|
|
|
Restricted Stock Awards Granted |
|
|
|
|
|
445,490
|
|
|
Equity Incentive Plan for Non-Employee Directors |
|
|
|
|
|
$ 3,258,311
|
|
|
Unrelated Private Investors [Member] |
|
|
|
|
|
|
|
|
Common share sold |
|
|
|
|
|
598,054
|
|
|
Common share sold amount |
|
|
|
|
|
$ 4,283,387
|
|
|
Related Party [Member] |
|
|
|
|
|
|
|
|
Accounts payable to related party |
|
|
|
|
|
78,101
|
|
|
Cash |
|
|
|
|
|
$ 1,240,781
|
|
|
Common stock shares issuance |
|
|
|
|
|
195,435
|
|
|
Proceed from related party |
|
|
|
|
|
$ 1,318,882
|
|
|
Black Scholes Pricing Model [Member] |
|
|
|
|
|
|
|
|
Grants shares |
|
|
10,878
|
|
|
|
|
|
Grants shares, amount |
|
|
$ 3,626
|
|
|
|
|
|
Expected Dividends |
|
|
0.00%
|
|
|
|
|
|
Proceed from related party |
|
|
$ 50,000
|
|
|
|
|
|
Average weighted remaining contructual life in years |
|
|
5 years 3 months 21 days
|
|
|
|
|
|
Discount rates |
|
|
3.88%
|
|
|
|
|
|
Volatility range |
|
|
112.25%
|
|
|
|
|
|
Common stock value |
|
|
$ 50,000
|
|
|
|
|
|
Employee Stock Option Replacement Program [Member] |
|
|
|
|
|
|
|
|
Outstanding number of option |
|
230,064
|
|
|
|
|
|
|
Expected Term |
|
5 years 1 month 6 days
|
|
|
|
|
|
|
Expected Dividends |
|
0.00%
|
|
|
|
|
|
|
Risk Free Rate |
|
4.29%
|
|
|
|
|
|
|
Common stock option shares approved |
|
981,174
|
|
|
|
|
|
|
Compensation expense award grant |
|
5,849,520
|
|
|
|
|
|
|
Expected Volatility |
|
122.46%
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
Common stock shares issuance |
|
|
|
|
|
|
78,021
|
|
Received from common stock shares issued |
|
|
|
|
|
|
$ 47
|
|
Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
Proceed from stock issuances |
|
|
|
$ 875,000
|
|
|
|
|
Incentive plan, description |
|
|
|
by the Company to such non-employee director, will not exceed $750,000 in total value or, in the event such non-employee director is first appointed or elected to the Board during such calendar year, $1,000,000 in total value
|
|
|
|
|
Shares remain available to be issued |
|
|
|
429,510
|
|
|
|
|
Equity Incentive Plan [Member] | Common Stock Options Member |
|
|
|
|
|
|
|
|
Director Compensation Expense - Equity |
|
|
|
|
|
$ 6,215,202
|
867,359
|
|
Awarded number of restricted stock |
|
|
|
|
|
1,031,425
|
|
|
Twenty Twenty One Incentive Plan [Member] |
|
|
|
|
|
|
|
|
Stock options, issued |
|
|
|
|
|
1,000,000
|
|
1,000,000
|
Twenty Twenty One Incentive Plan [Member] | June 5 2024 [Member] |
|
|
|
|
|
|
|
|
Stock options, issued |
|
292,515
|
|
|
|
1,031,425
|
|
|
Shares remain available to be issued |
|
|
|
|
|
261,090
|
|
|
2021 [Member] | Black Scholes Pricing Model [Member] |
|
|
|
|
|
|
|
|
Average weighted remaining contructual life in years |
|
|
|
|
|
10 years
|
|
|
Board Annual Service [Member] |
|
|
|
|
|
|
|
|
Restricted Stock Awards Granted |
|
|
|
|
|
18,819
|
|
|
Equity Incentive Plan for Non-Employee Directors |
|
|
|
|
|
$ 50,000
|
|
|
Fair Value of Restricted Stock Awards |
|
|
|
|
|
$ 187,673
|
|
|
Restricted Stock Awards Granted and Vested |
|
|
|
|
|
426,671
|
|
|
Director Compensation Expense - Equity |
|
|
|
|
|
$ 3,070,638
|
|
|
C E O Twenty Twenty Three Equity Award [Member] | Common Stock Options Member |
|
|
|
|
|
|
|
|
Awarded number of restricted stock |
|
50,251
|
|
|
|
|
|
|
Due amount for exchange of stock option |
|
$ 400,000
|
|
|
|
|
|
|
Awarded number of restricted stock per share |
|
$ 7.96
|
|
|
|
|
|
|
Compensation expense |
|
$ 338,819
|
|
|
|
|
|
|
Expected Term |
|
5 years 1 month 6 days
|
|
|
|
|
|
|
Expected Volatility |
|
122.46%
|
|
|
|
|
|
|
Expected Dividends |
|
0.00%
|
|
|
|
|
|
|
Risk Free Rate |
|
4.29%
|
|
|
|
|
|
|
Private Placement Securities [Member] |
|
|
|
|
|
|
|
|
Shares available for issuance, shares |
|
|
|
|
|
249,688
|
|
|
Exercise price |
|
|
|
|
|
$ 16.80
|
|
|
Offering price |
|
|
|
|
|
$ 16.80
|
|
|
Common stock share issued, restricted |
|
|
|
|
|
249,688
|
|
|
Investor Private Placement Member |
|
|
|
|
|
|
|
|
Proceed from stock issuances |
|
|
|
|
|
|
$ 640,000
|
|
Stock Warrants Issued [Member] |
|
|
|
|
|
|
|
|
Restricted Stock Awards Granted |
|
|
|
|
|
78,021
|
|
|
Warrants issued to related parties |
|
|
|
|
|
6,185
|
|
|
Warrants issued to purchase common stock |
|
|
|
|
|
30,924
|
|
|
Common Stock Warrants Issued |
|
|
|
|
|
642,397
|
|
|
Warrants issued to related party |
|
|
|
|
|
65,000
|
|
|
Private placement warrants issued |
|
|
|
|
|
499,376
|
|
|